应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IOVA Iovance Biotherapeutics, Inc.
盘后交易 11-22 18:27:11 EST
8.55
+0.31
+3.76%
盘后
8.62
+0.07
+0.82%
18:18 EST
最高
8.72
最低
8.08
成交量
926.89万
今开
8.15
昨收
8.24
日振幅
7.71%
总市值
26.06亿
流通市值
19.24亿
总股本
3.05亿
成交额
7,863万
换手率
4.12%
流通股本
2.25亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Iovance Biotherapeutics, Inc.盘中异动 临近午盘股价大涨5.10%报8.66美元
市场透视 · 00:50
Iovance Biotherapeutics, Inc.盘中异动 临近午盘股价大涨5.10%报8.66美元
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.01%
市场透视 · 11-19
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.01%
Iovance Biotherapeutics, Inc.2024财年第三财季实现净利润-83.54百万美元,同比增加26.72%
市场透视 · 11-17
Iovance Biotherapeutics, Inc.2024财年第三财季实现净利润-83.54百万美元,同比增加26.72%
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.14%
市场透视 · 11-12
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.14%
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.05%报10.05美元
市场透视 · 11-11
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.05%报10.05美元
Iovance Biotherapeutics, Inc.盘中异动 快速下跌13.53%
市场透视 · 11-08
Iovance Biotherapeutics, Inc.盘中异动 快速下跌13.53%
Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻
路透中文 · 11-06
Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻
Iovance Biotherapeutics, Inc.盘中异动 早盘急速上涨5.06%
市场透视 · 11-06
Iovance Biotherapeutics, Inc.盘中异动 早盘急速上涨5.06%
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.12%报10.98美元
市场透视 · 11-02
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.12%报10.98美元
Iovance Biotherapeutics, Inc.盘中异动 大幅下跌5.14%
市场透视 · 10-31
Iovance Biotherapeutics, Inc.盘中异动 大幅下跌5.14%
Iovance Biotherapeutics, Inc.盘中异动 下午盘大幅拉升5.01%报11.21美元
市场透视 · 10-29
Iovance Biotherapeutics, Inc.盘中异动 下午盘大幅拉升5.01%报11.21美元
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.02%
市场透视 · 10-25
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.02%
Iovance Biotherapeutics, Inc.盘中异动 早盘快速拉升5.01%报10.31美元
市场透视 · 10-24
Iovance Biotherapeutics, Inc.盘中异动 早盘快速拉升5.01%报10.31美元
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.13%
市场透视 · 10-21
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.13%
Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.02%报9.84美元
市场透视 · 10-18
Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.02%报9.84美元
Iovance Biotherapeutics, Inc.盘中异动 下午盘急速跳水5.07%
市场透视 · 10-08
Iovance Biotherapeutics, Inc.盘中异动 下午盘急速跳水5.07%
Iovance Biotherapeutics, Inc.盘中异动 早盘快速上涨5.02%
市场透视 · 10-04
Iovance Biotherapeutics, Inc.盘中异动 早盘快速上涨5.02%
Iovance Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.03%
市场透视 · 10-03
Iovance Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.03%
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大涨5.01%
市场透视 · 09-19
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大涨5.01%
Iovance Biotherapeutics, Inc.盘中异动 快速拉升5.10%报10.31美元
市场透视 · 09-17
Iovance Biotherapeutics, Inc.盘中异动 快速拉升5.10%报10.31美元
加载更多
公司概况
公司名称:
Iovance Biotherapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Iovance Biotherapeutics, Inc.是一家新兴的生物技术公司,专注于培养细胞,使用自体肿瘤浸润淋巴细胞(TIL)治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。
发行价格:
--
{"stockData":{"symbol":"IOVA","market":"US","secType":"STK","nameCN":"Iovance Biotherapeutics, Inc.","latestPrice":8.55,"timestamp":1732309200000,"preClose":8.24,"halted":0,"volume":9268937,"hourTrading":{"tag":"盘后","latestPrice":8.62,"preClose":8.55,"latestTime":"18:18 EST","volume":3844567,"amount":32871624.53505,"timestamp":1732317518811},"delay":0,"floatShares":224977109,"shares":304780790,"eps":-1.477851,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.31,"latestTime":"11-22 18:27:11 EST","open":8.15,"high":8.715,"low":8.08,"amount":78629690.22218001,"amplitude":0.077063,"askPrice":8.62,"askSize":216,"bidPrice":8.55,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.477851,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"adjPreClose":8.24,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.14,"preClose":8.24,"latestTime":"09:29 EST","volume":33535,"amount":274417.6595375,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":8.62,"preClose":8.55,"latestTime":"18:18 EST","volume":3844567,"amount":32871624.53505,"timestamp":1732317518811},"volumeRatio":0.877664,"impliedVol":0.7066,"impliedVolPercentile":0.0873},"requestUrl":"/m/hq/s/IOVA","defaultTab":"news","newsList":[{"id":"2485470296","title":"Iovance Biotherapeutics, Inc.盘中异动 临近午盘股价大涨5.10%报8.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485470296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485470296?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:50","pubTimestamp":1732294228,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时50分,Iovance Biotherapeutics, Inc.股票出现波动,股价快速上涨5.10%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300502898e44335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300502898e44335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2484603684","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484603684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484603684?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:16","pubTimestamp":1731946619,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时16分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅拉升5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900165998e434d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900165998e434d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2484548830","title":"Iovance Biotherapeutics, Inc.2024财年第三财季实现净利润-83.54百万美元,同比增加26.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484548830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484548830?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773040,"startTime":"0","endTime":"0","summary":"11月17日,Iovance Biotherapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-83.54百万美元,同比增加26.72%;其中营业收入为58.56百万美元,同比增加12386.14%,每股基本收益为-0.28美元。从资产负债表来看,Iovance Biotherapeutics, Inc.总负债2.18亿美元,其中短期债务11.55百万美元,资产负债比为4.55,流动比率为4.23。机构评级:截至2024年11月17日,当前有13家机构对Iovance Biotherapeutics, Inc.目标价做出预测,其中目标均价为23.77美元,其中最低目标价为10.00美元,最高目标价为34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000519a23e0794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000519a23e0794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA"],"gpt_icon":0},{"id":"2482861880","title":"Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482861880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482861880?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:52","pubTimestamp":1731423178,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时52分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速下跌5.14%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222525998e42185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222525998e42185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2482352738","title":"Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.05%报10.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482352738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482352738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:36","pubTimestamp":1731335806,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时36分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅下跌5.05%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223647971a5b33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223647971a5b33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2481101674","title":"Iovance Biotherapeutics, Inc.盘中异动 快速下跌13.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101674?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076306,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速下跌13.53%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314695bdeee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314695bdeee4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2481883489","title":"Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481883489","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481883489?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:33","pubTimestamp":1730903615,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻Iovance Biotherapeutics Inc IOVA.OQ IOVA.O将于11月7日公布截至2024年9月30日的财报,预计该公司的季度收入将有所增长。LSEG 分析师对 Iovance Biotherapeutics Inc 的平均预期是每股亏损 30 美分。华尔街对 Iovance Biotherapeutics Inc 的 12 个月目标价中位数为 24.00 美元,高于其最新收盘价 11.66 美元。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD2MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOVA"],"gpt_icon":0},{"id":"2481398385","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481398385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481398385?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903469,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分,Iovance Biotherapeutics, Inc.股票出现异动,股价快速拉升5.06%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223109971a4b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223109971a4b84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2480830766","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.12%报10.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480830766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480830766?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:48","pubTimestamp":1730483292,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时48分,Iovance Biotherapeutics, Inc.股票出现波动,股价快速拉升5.12%。截至发稿,该股报10.98美元/股,成交量284.289万股,换手率0.94%,振幅3.78%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102014812971a3eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102014812971a3eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2479032463","title":"Iovance Biotherapeutics, Inc.盘中异动 大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479032463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479032463?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:16","pubTimestamp":1730387805,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时16分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速下跌5.14%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.57%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031231645a2029a4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031231645a2029a4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2479437846","title":"Iovance Biotherapeutics, Inc.盘中异动 下午盘大幅拉升5.01%报11.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479437846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479437846?lang=zh_cn&edition=full","pubTime":"2024-10-29 01:07","pubTimestamp":1730135272,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日01时07分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102901075298e3ee2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102901075298e3ee2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2478935418","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478935418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478935418?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:49","pubTimestamp":1729864166,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时49分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速拉升5.02%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214926971a2550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214926971a2550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2477263970","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘快速拉升5.01%报10.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477263970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477263970?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:37","pubTimestamp":1729777072,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时37分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅拉升5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421375398e3e3db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421375398e3e3db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2477386475","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477386475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477386475?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:01","pubTimestamp":1729522917,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时01分,Iovance Biotherapeutics, Inc.股票出现异动,股价急速下跌5.13%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123015898e3d90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123015898e3d90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2476485268","title":"Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.02%报9.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476485268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476485268?lang=zh_cn&edition=full","pubTime":"2024-10-18 01:48","pubTimestamp":1729187317,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日01时48分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅上涨5.02%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018014837971a0e4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018014837971a0e4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2473384484","title":"Iovance Biotherapeutics, Inc.盘中异动 下午盘急速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473384484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473384484?lang=zh_cn&edition=full","pubTime":"2024-10-08 01:56","pubTimestamp":1728323763,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日01时56分,Iovance Biotherapeutics, Inc.股票出现异动,股价急速下挫5.07%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080156039719eb38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080156039719eb38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2472952087","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472952087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472952087?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:35","pubTimestamp":1728048953,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时35分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅上涨5.02%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042135539719e5fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042135539719e5fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2472974570","title":"Iovance Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472974570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472974570?lang=zh_cn&edition=full","pubTime":"2024-10-03 02:24","pubTimestamp":1727893499,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日02时24分,Iovance Biotherapeutics, Inc.股票出现异动,股价快速上涨5.03%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.21%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003022500ab677c0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003022500ab677c0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2468724595","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468724595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468724595?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:30","pubTimestamp":1726752650,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时30分,Iovance Biotherapeutics, Inc.股票出现波动,股价快速上涨5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192130519719bd4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192130519719bd4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2468366992","title":"Iovance Biotherapeutics, Inc.盘中异动 快速拉升5.10%报10.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468366992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468366992?lang=zh_cn&edition=full","pubTime":"2024-09-17 23:22","pubTimestamp":1726586542,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日23时22分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速上涨5.10%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.86%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723222298e37cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723222298e37cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iovance.com","stockEarnings":[{"period":"1week","weight":-0.0407},{"period":"1month","weight":-0.1727},{"period":"3month","weight":-0.3058},{"period":"6month","weight":-0.1768},{"period":"1year","weight":0.5273},{"period":"ytd","weight":0.0135}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Iovance Biotherapeutics, Inc.是一家新兴的生物技术公司,专注于培养细胞,使用自体肿瘤浸润淋巴细胞(TIL)治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.066181},{"month":2,"riseRate":0.555556,"avgChangeRate":0.167188},{"month":3,"riseRate":0.2,"avgChangeRate":-0.027658},{"month":4,"riseRate":0.3,"avgChangeRate":-0.022763},{"month":5,"riseRate":0.4,"avgChangeRate":-0.049074},{"month":6,"riseRate":0.5,"avgChangeRate":0.159675},{"month":7,"riseRate":0.7,"avgChangeRate":0.002291},{"month":8,"riseRate":0.4,"avgChangeRate":0.012998},{"month":9,"riseRate":0.3,"avgChangeRate":-0.084178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.015002},{"month":11,"riseRate":0.7,"avgChangeRate":0.041989},{"month":12,"riseRate":0.666667,"avgChangeRate":0.07448}],"exchange":"NASDAQ","name":"Iovance Biotherapeutics, Inc.","nameEN":"Iovance Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Iovance Biotherapeutics, Inc.,IOVA,Iovance Biotherapeutics, Inc.股票,Iovance Biotherapeutics, Inc.股票老虎,Iovance Biotherapeutics, Inc.股票老虎国际,Iovance Biotherapeutics, Inc.行情,Iovance Biotherapeutics, Inc.股票行情,Iovance Biotherapeutics, Inc.股价,Iovance Biotherapeutics, Inc.股市,Iovance Biotherapeutics, Inc.股票价格,Iovance Biotherapeutics, Inc.股票交易,Iovance Biotherapeutics, Inc.股票购买,Iovance Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}